Monashee Investment Management »

Korro Bio shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.4M 91k 47.93

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Structure Therapeutics Sponsored Ads (GPCR)
Aercap Holdings Nv SHS (AER)
PG&E Corporation (PCG)
Korro Bio (KRRO)
Eyepoint Pharmaceuticals Com New (EYPT)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)

View all positions for Monashee Investment Management

Top funds holding Korro Bio

Atlas Venture Life Science Advisors
NEA Management Company
Eventide Asset Management
Citadel Advisors
Cormorant Asset Management
Artal Group
Qiming U.S. Ventures Management
72 Investment Holdings
Vanguard Group
Point72 Asset Management
Monashee Investment Management
Citigroup
Jane Street
Bank of America Corporation
North Star Investment Management

View all funds holding Korro Bio